Target intelligence / Profile preview

Ribosomal protein S26 pseudogene 18 (RPS26P18)

Target
RPS26P18
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein S26 pseudogene 18 (RPS26P18) is a non-functional, processed pseudogene in the human genome that is homologous to the ribosomal protein S26 (RPS26) gene[2][5]. RPS26 is a component of the small 40S subunit of the ribosome and is involved in mRNA translation[1][3]. However, “pseudogene 18” does not encode a functional protein and is not associated with any known cellular or disease function[2][5]. It serves primarily as a genomic remnant arising from gene duplication or retrotransposition and is part of a larger family of similar ribosomal protein pseudogenes dispersed through the genome[1][4]. Pseudogenes are sometimes useful in evolutionary biology or genomics as landmarks but do not have therapeutic, diagnostic, or clear biological utility. Key distinction: The functional ribosomal protein S26 (RPS26) is linked with ribosome assembly and genetic disease (e.g., Diamond-Blackfan anemia), but RPS26P18 is an inactive, non-coding pseudogene unrelated to these functions[1][3][4].

02

Mechanism of action

None (no drug action reported against this pseudogene)

03

Biological functions

None (no known coding function or biological activity; pseudogenes typically do not have direct biological function)
04

Disease associations

None (no evidence this pseudogene is involved directly in human disease)
05

Safety considerations

None (no therapies or drugs are associated with this gene, so no known safety concerns)
06

Interacting drugs

None (no drugs known to interact with or target this pseudogene)
07

Biomarkers

None (not used as a biomarker for disease or therapy)

Beyond the preview

Go deeper on Ribosomal protein S26 pseudogene 18 (RPS26P18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S26 pseudogene 18 (RPS26P18).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call